2,4-thiazolidinedione has been researched along with Cancer of Prostate in 3 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cotreatment with GW9662 (GW), a PPARgamma antagonist, significantly inhibited this effect, whereas overexpressing the receptor enhanced it." | 1.35 | PPARgamma1 as a molecular target of eicosapentaenoic acid in human colon cancer (HT-29) cells. ( Allred, CD; Kilgore, MW; Southard, RC; Talbert, DR; Wang, X, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Metwally, K | 1 |
| Pratsinis, H | 1 |
| Kletsas, D | 1 |
| Steffan, JJ | 1 |
| Dykes, SS | 1 |
| Coleman, DT | 1 |
| Adams, LK | 1 |
| Rogers, D | 1 |
| Carroll, JL | 1 |
| Williams, BJ | 1 |
| Cardelli, JA | 1 |
| Allred, CD | 1 |
| Talbert, DR | 1 |
| Southard, RC | 1 |
| Wang, X | 1 |
| Kilgore, MW | 1 |
1 trial available for 2,4-thiazolidinedione and Cancer of Prostate
| Article | Year |
|---|---|
Supporting a role for the GTPase Rab7 in prostate cancer progression.
Topics: Animals; Cell Line, Tumor; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neop | 2014 |
2 other studies available for 2,4-thiazolidinedione and Cancer of Prostate
| Article | Year |
|---|---|
Novel 2,4- thiazolidinediones: Synthesis, in vitro cytotoxic activity, and mechanistic investigation.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Survival; Fem | 2017 |
PPARgamma1 as a molecular target of eicosapentaenoic acid in human colon cancer (HT-29) cells.
Topics: Anilides; Cell Proliferation; Colonic Neoplasms; Eicosapentaenoic Acid; Gene Expression Regulation; | 2008 |